GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.

Guangzhou Kingmed Diagnostics Group Co., Ltd.

Equities

603882

CNE100002VW1

Healthcare Facilities & Services

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-05-07 EDT			5-day change	1st Jan Change
39.61 ^CNY	-3.04%		+3.29%	-36.69%

04-25	Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-25	Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on December 19, 2023.

January 02, 2024

From December 18, 2023 to December 31, 2023, the company has repurchased 647,000 shares, representing 0.14% for CNY 39.99 million. With this, the company has completed the repurchase of 647,000 shares, representing 0.14% for CNY 39.99 million under the buyback announced on December 19, 2023.

Latest news about Guangzhou Kingmed Diagnostics Group Co., Ltd.

Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-25	CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024.	04-09	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on January 20, 2024, has closed with 1,781,400 shares, representing 0.38% for CNY 99.99 million.	04-08	CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024.	04-01	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	01-19	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan.	01-18	CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on December 19, 2023.	01-11	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on December 19, 2023, has closed with 1,696,800 shares, representing 0.36% for CNY 99.99 million.	01-10	CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on December 19, 2023.	01-02	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	12-18	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan.	12-17	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.(SHSE:603882) dropped from SSE 180 Index	12-08	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.(SHSE:603882) dropped from Shanghai Stock Exchange 180 Value Index	12-08	CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on September 19, 2023.	11-14	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on September 19, 2023, has closed with 787,600 shares, representing 0.17% for CNY 49.99 million.	11-13	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on September 19, 2023.	23-10-09	CI
China's Small Hospitals, Clinics Banking on AI to Bridge Barriers in Diagnosis, Treatment	23-09-19	MT
Kingmed Diagnostics to Repurchase Up to 50 Million Yuan Shares	23-09-19	MT
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.	23-09-18	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan.	23-09-17	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Guangzhou Xinhongrui Investment Consulting Partnership (Limited Partnership), Guangzhou Xinhongyu Investment Consulting Partnership (Limited Partnership), Guangzhou Xinhongyu Investment Consulting Partnership (Limited Partnership) and Xie Jiangtao agreed to acquire 72% stake in Guangzhou Jinli Pharmaceutical Technology Co., Ltd. from Guangzhou Kingmed Diagnostics Group Co., Ltd. for CNY 220 million.	23-08-11	CI
GeneMind Biosciences Company Limited announced that it has received CNY 400 million in funding from Guangzhou Kingmed Diagnostics Group Co., Ltd., Shanghai Guoxin Investment Development Co. Ltd., Shenzhen High-Tech Investment Group Co., Ltd., Changzhou Shuangye Venture Capital, Hunan Caixin Capital Management Co., Ltd., Guochuang Zhiyuan Private Equity Fund	23-08-01	CI

Chart Guangzhou Kingmed Diagnostics Group Co., Ltd.

Duration

Period

Chart Guangzhou Kingmed Diagnostics Group Co., Ltd.

More charts

Company Profile

Guangzhou Kingmed Diagnostics Group Co Ltd is a company that mainly provides medical diagnosis services. The Company is also engaged in other businesses, including sales of diagnostic products, provision of physical examination and cold chain logistics services.

Sector

Healthcare Facilities & Services

Calendar

2024-05-20 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Guangzhou Kingmed Diagnostics Group Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

39.61 CNY

Average target price

71.03 CNY

Spread / Average Target

+79.33%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-36.69%	2.55B
SONIC HEALTHCARE LIMITED	-17.18%	8.39B
RADNET, INC.	+45.61%	3.74B
SYNLAB AG	-8.06%	2.48B
DR. LAL PATHLABS LIMITED	-12.35%	2.32B
NEOGENOMICS, INC.	-6.49%	1.93B
FLEURY S.A.	-17.24%	1.6B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-37.21%	1.28B
METROPOLIS HEALTHCARE LIMITED	+5.14%	1.08B
OPKO HEALTH, INC.	-17.22%	871M

Medical & Diagnostic Laboratories